Defining the molecular basis for the β-catenin and CDC73 interaction
RNA polymerase II (Pol II) is required for expression of protein coding genes. To initiate gene transcription, Pol II is recruited to gene promoters by transcription factors. Gene specific transcription factors, including β-catenin, a component of the Wnt signaling pathway, are used to regulate gene...
Main Author: | |
---|---|
Other Authors: | |
Format: | Thesis |
Published: |
Massachusetts Institute of Technology
2022
|
Online Access: | https://hdl.handle.net/1721.1/144639 |
_version_ | 1811078448109584384 |
---|---|
author | Lima, Bruna R. |
author2 | Vos, Seychelle |
author_facet | Vos, Seychelle Lima, Bruna R. |
author_sort | Lima, Bruna R. |
collection | MIT |
description | RNA polymerase II (Pol II) is required for expression of protein coding genes. To initiate gene transcription, Pol II is recruited to gene promoters by transcription factors. Gene specific transcription factors, including β-catenin, a component of the Wnt signaling pathway, are used to regulate gene expression in response to developmental or environmental cues. Previous studies reported that β-catenin binds to the central region of CDC73, a subunit of the Polymerase Associated Factor 1 complex (PAF). PAF associates with Pol II during transcription elongation to stimulate processive elongation and co-transcriptional histone modification. Genetic studies have shown that CDC73 is required for expression of Wnt signaling pathway genes. In addition, such studies have hypothesized that the interaction between β-catenin and CDC73 was used to recruit Pol II to genes through PAF. In this work I explored how the CDC73•β-catenin interaction is used to regulate gene expression. My data indicates that CDC73 uses its middle region to associate with either PAF or β-catenin but cannot associate with both proteins simultaneously. Both CDC73 and β-catenin weakly interact with nucleic acids meaning that this complex might need another protein factor to mediate their interaction with DNA. To solve the structure of the β-catenin•CDC73 complex, purification strategies require some optimization to isolate a stable complex. Solving the structure of β-catenin•CDC73 complex will define the exact nature of their interaction. Moreover, it will allow for cellular studies of β-catenin•CDC73 and PAF to understand if the complexes are differentially used to regulate gene expression. Together, the work presented in this thesis provide new insights on the β-catenin•CDC73 interaction in comparison with the interaction of CDC73 with PAF. |
first_indexed | 2024-09-23T10:59:50Z |
format | Thesis |
id | mit-1721.1/144639 |
institution | Massachusetts Institute of Technology |
last_indexed | 2024-09-23T10:59:50Z |
publishDate | 2022 |
publisher | Massachusetts Institute of Technology |
record_format | dspace |
spelling | mit-1721.1/1446392022-08-30T03:45:09Z Defining the molecular basis for the β-catenin and CDC73 interaction Lima, Bruna R. Vos, Seychelle Massachusetts Institute of Technology. Computational and Systems Biology Program RNA polymerase II (Pol II) is required for expression of protein coding genes. To initiate gene transcription, Pol II is recruited to gene promoters by transcription factors. Gene specific transcription factors, including β-catenin, a component of the Wnt signaling pathway, are used to regulate gene expression in response to developmental or environmental cues. Previous studies reported that β-catenin binds to the central region of CDC73, a subunit of the Polymerase Associated Factor 1 complex (PAF). PAF associates with Pol II during transcription elongation to stimulate processive elongation and co-transcriptional histone modification. Genetic studies have shown that CDC73 is required for expression of Wnt signaling pathway genes. In addition, such studies have hypothesized that the interaction between β-catenin and CDC73 was used to recruit Pol II to genes through PAF. In this work I explored how the CDC73•β-catenin interaction is used to regulate gene expression. My data indicates that CDC73 uses its middle region to associate with either PAF or β-catenin but cannot associate with both proteins simultaneously. Both CDC73 and β-catenin weakly interact with nucleic acids meaning that this complex might need another protein factor to mediate their interaction with DNA. To solve the structure of the β-catenin•CDC73 complex, purification strategies require some optimization to isolate a stable complex. Solving the structure of β-catenin•CDC73 complex will define the exact nature of their interaction. Moreover, it will allow for cellular studies of β-catenin•CDC73 and PAF to understand if the complexes are differentially used to regulate gene expression. Together, the work presented in this thesis provide new insights on the β-catenin•CDC73 interaction in comparison with the interaction of CDC73 with PAF. S.M. 2022-08-29T16:01:31Z 2022-08-29T16:01:31Z 2022-05 2022-06-14T23:23:23.673Z Thesis https://hdl.handle.net/1721.1/144639 In Copyright - Educational Use Permitted Copyright MIT http://rightsstatements.org/page/InC-EDU/1.0/ application/pdf Massachusetts Institute of Technology |
spellingShingle | Lima, Bruna R. Defining the molecular basis for the β-catenin and CDC73 interaction |
title | Defining the molecular basis for the β-catenin and CDC73 interaction |
title_full | Defining the molecular basis for the β-catenin and CDC73 interaction |
title_fullStr | Defining the molecular basis for the β-catenin and CDC73 interaction |
title_full_unstemmed | Defining the molecular basis for the β-catenin and CDC73 interaction |
title_short | Defining the molecular basis for the β-catenin and CDC73 interaction |
title_sort | defining the molecular basis for the β catenin and cdc73 interaction |
url | https://hdl.handle.net/1721.1/144639 |
work_keys_str_mv | AT limabrunar definingthemolecularbasisforthebcateninandcdc73interaction |